Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Meinken

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Radioimmunodetection of human tumor xenografts by monoclonal antibody F(ab')2 fragmentsD Herlyn, J Powe, D L Munz, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Radioactive gold cluster immunoconjugates: potential agents for cancer therapyJ F Hainfeld, C J Foley, S C Srivastava, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1990
Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistributionJ M Rosen, S P Butler, G E Meinken, et al.
Radiology|August 1, 1980
Splenic sequestration of 99mTc labeled, heat treated red blood cellsH L Atkins, A G Goldman, R G Fairchild, et al.
Nuclear Medicine and Biology|February 1, 1993
Abscess scintigraphy with 99mTc-human immunoglobulin (IgG) using a one-step labeling methodZ H Oster, P Som, B A Rhodes, et al.
International Journal of Nuclear Medicine and Biology|January 1, 1985
The development and in-vivo behavior of tin containing radiopharmaceuticals--I. Chemistry, preparation, and biodistribution in small animalsS C Srivastava, G E Meinken, P Richards, et al.
Nuclear Medicine and Biology|August 1, 1993
Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic methodJ F Gestin, A Faivre-Chauvet, R C Mease, et al.
Nuclear Medicine and Biology|August 1, 1993
Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude miceA Faivre-Chauvet, J F Gestin, R C Mease, et al.
Nuclear Medicine Communications|September 1, 1996
Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibodyA Faivre-Chauvet, R C Mease, A Chetanneau, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1985
Thrombus radioimmunoscintigraphy: an approach using monoclonal antiplatelet antibodyZ H Oster, S C Srivastava, P Som, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Radioimmunodetection of human tumor xenografts by monoclonal antibody F(ab')2 fragmentsD Herlyn, J Powe, D L Munz, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Radioactive gold cluster immunoconjugates: potential agents for cancer therapyJ F Hainfeld, C J Foley, S C Srivastava, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1990
Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistributionJ M Rosen, S P Butler, G E Meinken, et al.
Radiology|August 1, 1980
Splenic sequestration of 99mTc labeled, heat treated red blood cellsH L Atkins, A G Goldman, R G Fairchild, et al.
Nuclear Medicine and Biology|February 1, 1993
Abscess scintigraphy with 99mTc-human immunoglobulin (IgG) using a one-step labeling methodZ H Oster, P Som, B A Rhodes, et al.
International Journal of Nuclear Medicine and Biology|January 1, 1985
The development and in-vivo behavior of tin containing radiopharmaceuticals--I. Chemistry, preparation, and biodistribution in small animalsS C Srivastava, G E Meinken, P Richards, et al.
Nuclear Medicine and Biology|August 1, 1993
Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic methodJ F Gestin, A Faivre-Chauvet, R C Mease, et al.
Nuclear Medicine and Biology|August 1, 1993
Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude miceA Faivre-Chauvet, J F Gestin, R C Mease, et al.
Nuclear Medicine Communications|September 1, 1996
Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibodyA Faivre-Chauvet, R C Mease, A Chetanneau, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1985
Thrombus radioimmunoscintigraphy: an approach using monoclonal antiplatelet antibodyZ H Oster, S C Srivastava, P Som, et al.
Pageof 3